Comerica Bank Decreases Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Comerica Bank cut its stake in Integer Holdings Co. (NYSE:ITGR – Get Rating) by 9.0% in the third quarter, HoldingsChannel.com reports. The fund owned 28,128 shares of the medical equipment provider’s stock after selling 2,787 shares during the period. Comerica Bank’s holdings in Integer were worth $1,583,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Covestor Ltd grew its stake in shares of Integer by 420.6% during the 1st quarter. Covestor Ltd now owns 328 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 265 shares during the period. First Horizon Advisors Inc. increased its holdings in Integer by 6,370.0% during the second quarter. First Horizon Advisors Inc. now owns 647 shares of the medical equipment provider’s stock valued at $46,000 after buying an additional 637 shares during the last quarter. Captrust Financial Advisors raised its position in Integer by 56.3% in the first quarter. Captrust Financial Advisors now owns 2,408 shares of the medical equipment provider’s stock worth $194,000 after acquiring an additional 867 shares during the period. Summit Trail Advisors LLC purchased a new position in shares of Integer during the 2nd quarter worth $200,000. Finally, Versor Investments LP purchased a new stake in shares of Integer in the 2nd quarter worth $217,000. Institutional investors own 98.42% of the company’s stock.

Integer Stock Up 1.3 %

Shares of ITGR opened at $74.21 on Friday. Integer Holdings Co. has a 12-month low of $50.05 and a 12-month high of $88.58. The company has a current ratio of 2.80, a quick ratio of 1.74 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $2.46 billion, a PE ratio of 34.52 and a beta of 1.17. The business’s 50 day moving average is $70.58 and its 200 day moving average is $66.75.

Integer (NYSE:ITGR – Get Rating) last issued its earnings results on Thursday, October 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.06. Integer had a net margin of 5.47% and a return on equity of 9.24%. The firm had revenue of $342.68 million during the quarter, compared to analyst estimates of $343.15 million. Research analysts expect that Integer Holdings Co. will post 3.77 earnings per share for the current fiscal year.

Insider Transactions at Integer

In other Integer news, CEO Joseph W. Dziedzic purchased 4,000 shares of the stock in a transaction that occurred on Friday, December 16th. The stock was purchased at an average price of $61.95 per share, with a total value of $247,800.00. Following the acquisition, the chief executive officer now owns 122,378 shares in the company, valued at $7,581,317.10. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.01% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. StockNews.com initiated coverage on Integer in a report on Wednesday, October 12th. They set a “hold” rating for the company. Benchmark decreased their target price on shares of Integer to $90.00 in a research note on Tuesday, November 1st. Finally, KeyCorp dropped their price target on shares of Integer from $97.00 to $84.00 and set an “overweight” rating for the company in a research report on Thursday, October 6th.

Integer Profile

(Get Rating)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.